These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2457399)

  • 21. Ganglioside treatments reduce locomotor hyperactivity after bilateral lesions of the entorhinal cortex.
    Ramirez JJ; Fass B; Karpiak SE; Steward O
    Neurosci Lett; 1987 Apr; 75(3):283-7. PubMed ID: 3587735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
    Wang H; Lynch JR; Song P; Yang HJ; Yates RB; Mace B; Warner DS; Guyton JR; Laskowitz DT
    Exp Neurol; 2007 Jul; 206(1):59-69. PubMed ID: 17521631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ganglioside therapy on experimental CS2 neuropathy.
    Maroni M; Colombi A; Gilioli R; Rota E; De Paschale G; Castano P; Foà V; Duca G
    Clin Toxicol; 1981 Dec; 18(12):1475-84. PubMed ID: 6277554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model.
    Lehmann HC; Lopez PH; Zhang G; Ngyuen T; Zhang J; Kieseier BC; Mori S; Sheikh KA
    J Neurosci; 2007 Jan; 27(1):27-34. PubMed ID: 17202469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histopathologic study of the use of gangliosides for nerve regeneration in rats after axonotmesis.
    Neto JC; Vasconcelos BC; Sobral AP; da Silva VA; Nogueira RV
    J Oral Maxillofac Surg; 2007 May; 65(5):870-4. PubMed ID: 17448835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gangliosides in neurological pharmacotherapy].
    Małecki A; Małecka E; Trzeciak HI
    Neurol Neurochir Pol; 1992; 26(5):695-701. PubMed ID: 1291908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganglioside treatment improves recovery of alternation behavior after unilateral entorhinal cortex lesion.
    Karpiak SE
    Exp Neurol; 1983 Aug; 81(2):330-9. PubMed ID: 6873218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monosialoganglioside GM1 treatment after a hypoxic-ischemic episode reduces the vulnerability of the fetal sheep brain to subsequent injuries.
    Tan WK; Williams CE; Mallard CE; Gluckman PD
    Am J Obstet Gynecol; 1994 Feb; 170(2):663-9. PubMed ID: 8116729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesions.
    Wójcik M; Ułas J; Oderfeld-Nowak B
    Neuroscience; 1982 Feb; 7(2):495-9. PubMed ID: 7078734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ganglioside treatments on lesion-induced behavioral impairments and sprouting in the CNS.
    Fass B; Ramirez JJ
    J Neurosci Res; 1984; 12(2-3):445-58. PubMed ID: 6502760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gangliosides and regeneration of the goldfish optic nerve in vivo and in vitro.
    Rahmann H; Rösner H; Sonnentag U; Esders S
    Neurochem Int; 1992 Apr; 20(3):371-83. PubMed ID: 1304332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function.
    Karpiak SE; Li YS; Mahadik SP
    Stroke; 1987; 18(1):184-7. PubMed ID: 3027926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of carbohydrate structures of gangliosides in the activity to regenerate the rat axotomized hypoglossal nerve.
    Itoh M; Fukumoto S; Iwamoto T; Mizuno A; Rokutanda A; Ishida HK; Kiso M; Furukawa K
    Glycobiology; 2001 Feb; 11(2):125-30. PubMed ID: 11287399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gangliosides as neurobiochemical markers].
    De Luka SR; Vrbaski SR; Protić S
    Med Pregl; 1996; 49(9-10):377-83. PubMed ID: 8999294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of gangliosides in brain development and the potential benefits of perinatal supplementation.
    Ryan JM; Rice GE; Mitchell MD
    Nutr Res; 2013 Nov; 33(11):877-87. PubMed ID: 24176227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some functional consequences of chronic GM1 ganglioside administration in brain damaged rats.
    Stein DG
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):405-13. PubMed ID: 2130658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ganglioside-induced enhancement of behavioral recovery after bilateral lesions of the entorhinal cortex.
    Ramirez JJ; Fass B; Kilfoil T; Henschel B; Grones W; Karpiak SE
    Brain Res; 1987 Jun; 414(1):85-90. PubMed ID: 3620925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration.
    Vyas AA; Patel HV; Fromholt SE; Heffer-Lauc M; Vyas KA; Dang J; Schachner M; Schnaar RL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8412-7. PubMed ID: 12060784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal plasticity: a major factor in the restoration of brain function after injury.
    Toffano G; Dal Toso R; Leon A; Consolazione A; Aldinio C; Mazzari S; Agnati LF
    Ann Ist Super Sanita; 1984; 20(1):93-8. PubMed ID: 6534241
    [No Abstract]   [Full Text] [Related]  

  • 40. Gangliosides' dual mode of action: a working hypothesis.
    Janigro D; Di Gregorio F; Vyskocil F; Gorio A
    J Neurosci Res; 1984; 12(2-3):499-509. PubMed ID: 6094839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.